{"id":"W4317796985","doi":"10.1016/j.jcin.2022.10.062","title":"Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial","year":2023,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canadian Heart Research Centre; St. Michael's Hospital","funders":"Duke Clinical Research Institute; National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; Relypsa; Regeneron Pharmaceuticals; National Institutes of Health; GlaxoSmithKline; HLS Therapeutics; Daiichi Sankyo Europe; Servier; Novo Nordisk; InfraRedx; Arbor Pharmaceuticals; Sunovion; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Abbott Laboratories; CSL Behring; Esperion Therapeutics; Philips; Amgen; Pfizer; American Regent; Omron Healthcare; Sanofi; Abbott Vascular; St. Jude Medical","keywords":"Medicine; Kidney disease; Cause of death; Internal medicine; Ischemia; Disease; Incidence (geometry); Cumulative incidence; Cardiology; Cohort","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00132824,0.001286818,0.002927284,0.0002311763,0.0004700618,0.001536579,0.0007456995,0.001135196,0.001632168],"category_scores_gemma":[0.001692731,0.0004203812,0.002252989,0.0003798525,0.0005712258,0.001043369,0.001007764,0.002853586,0.0002425085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004974934,"about_ca_system_score_gemma":0.0008745206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002252956,"about_ca_topic_score_gemma":0.005587627,"domain_scores_codex":[0.9993924,0.0002699968,0.00003270323,0.0001056961,0.00004692561,0.0001522485],"domain_scores_gemma":[0.9994357,0.0001098755,0.0001294508,0.0000623732,0.00003546861,0.0002270096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7139157,0.006776046,0.1942161,0.002462403,0.02055936,0.0005373053,0.0002614933,0.00387946,0.004155505,0.002498012,0.0150971,0.03564156],"study_design_scores_gemma":[0.2545772,0.02808845,0.6734971,0.0005556809,0.02650158,0.0004952748,0.0004681693,0.004929071,0.001017114,0.003868291,0.005834437,0.0001676931],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873701,0.006515424,0.0002328793,0.001229035,0.0004077108,0.0001359676,0.001361871,0.00003054258,0.002716345],"genre_scores_gemma":[0.9921691,0.002020751,0.0002911886,0.0008493818,0.0007001566,0.0002303208,0.002242599,0.000008743273,0.00148763],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002927284,"threshold_uncertainty_score":0.007024527,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03379579958924139,"score_gpt":0.3007114230613525,"score_spread":0.2669156234721111,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}